The company is one of the first to receive a “platform technology designation,” which could speed the review of certain gene ...

The FDA has introduced ELSA, a groundbreaking AI tool designed to expedite the review process for drugs and medical devices.

FDA announced the launch of Elsa, a generative AI tool designed to “help employees—from scientific reviewers to ...

Modern drug development approaches that integrate functional plans with larger business goals are needed for success in early ...